Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Scorpion

Product Description

Scorpion 150 pixels JPEG1.jpgThe KBiosystems’ Scorpion Stacking robot/stacker has a narrow footprint to ensure premium benchtop workspace is left available for the end user. Instant interface is offered with KBiosystems product range of microplate & microtube sealers, microplate & microtube printing and barcoder and also our colony picking instrumentation, but can be fully integrated with all other equipment such as plate readers, plate washing stations and as part of larger systems as and where required. The Scorpion has a standardised stack capacity of either 30 or 72 microplates, but we can accommodate other volumes of stack upon request. The Scorpion has the ability to handle lidded and non-lidded plate types with a fast cycle time for each. Available in both left and right hand feeds and the ability to extend the reach to a standard 62mm, longer upon request, the Scorpion is versatile and robust. Able to deal with all plate and tube heights the Scorpion has a “restack” option if plate arrangement is important.

Key Features:

Operator Friendly – Whether a stand alone system or part of a larger integrated system the Scorpion offers easy to use software allowing speed, reliability and robustness for any automation requirement.

Fast – Speed is always a strong requirement and the Scorpion can handle a single stack of 72 plates in just 10 minutes.

Versatile – The Scorpion is modular and also has the benefit of allowing twin systems to work in parallel to increase throughput.

Reliable – After years of producing stacking robots/stackers, KBiosystems have a depth of experience and knowledge in laboratory automation.

Perfect for Integration – Already integrated to a large number of systems working with multiple products from partnering companies.

Product Scorpion
Company KBiosystems
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

KBiosystems
Units 5 to 10 Paycocke Close Basildon Essex

Tel: +44 (0) 1268 522431
Fax: +44 (0) 1268 270231
Email: sales@kbiosystems.com



Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!